Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in People With Multiple Sclerosis

NCT04834401 is registered in ClinicalTrials.gov with St. Barnabas Medical Center as lead sponsor.

NCT NCT04834401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04834401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in People With Multiple Sclerosis
Lead sponsor
St. Barnabas Medical Center
Phase
Observational
Overall status
Completed
Start date
March 22, 2021
Completion date
May 17, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, multiple sclerosis